ResearcherAsahikawa Medical UniversityNo recent work listed

Tsuguhito Ota

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2216-8459; OpenAlex author ID A5103263066. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper

Papers 1

Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Last author DOI 10.1111/cas.14232 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yohei Kitano · 1 shared paper, 2020 · strength 0.11
- Paper Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. DOI 10.1111/cas.14232 ↗
Satoshi Fujii · 1 shared paper, 2020 · strength 0.11
- Paper Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. DOI 10.1111/cas.14232 ↗
Kenji Takahashi · 1 shared paper, 2020 · strength 0.11
- Paper Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. DOI 10.1111/cas.14232 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.